These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23357107)

  • 1. Variability of new bone mineral metabolism markers in patients treated with maintenance hemodialysis: implications for clinical decision making.
    Cavalier E; Delanaye P; Moranne O
    Am J Kidney Dis; 2013 May; 61(5):847-8. PubMed ID: 23357107
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study of concerning factors of decreased bone mineral content in hemodialysis patients].
    Kohara N
    Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):587-96. PubMed ID: 1920939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and utility of a multi-dimensional grid to assess individual mineral metabolism control in hemodialysis patients: A potential aid for therapeutic decision making?
    Morton AR; Murphy S; Hirsch D; Leblanc M; Barré P; Lok C; Hercz G; Hodsman A; Reslerova M; Levin A
    Hemodial Int; 2010 Apr; 14(2):200-10. PubMed ID: 20337745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene polymorphism association studies in dialysis: bone and mineral metabolism.
    Erturk S;
    Semin Dial; 2006; 19(3):232-7. PubMed ID: 16689975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density by quantitative digital radiography in patients with end-stage renal failure beginning replacement hemodialysis treatment and after one year of treatment.
    Pecovnik Balon B; Zavratnik A
    Nephrol Dial Transplant; 1998 Jul; 13(7):1899. PubMed ID: 9681769
    [No Abstract]   [Full Text] [Related]  

  • 6. [Investigation of the bone mineral density in hemodialysis patients for different terms].
    Tao L; Xu H; Sun M; Ikeda T
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):177-8. PubMed ID: 11938784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sex hormone metabolism and sexual dysfunction in chronic kidney failure with maintenance hemodialysis therapy].
    Kinouchi T; Koide K; Shimizu N
    Nihon Rinsho; 1992 Jan; 50 Suppl():584-93. PubMed ID: 1578742
    [No Abstract]   [Full Text] [Related]  

  • 8. Disorders of protein and lipid metabolism associated with chronic renal failure and chronic dialysis.
    Krumlovsky FA
    Ann Clin Lab Sci; 1981; 11(4):350-60. PubMed ID: 7023349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Catecholamine metabolism in chronic kidney failure with hemodialysis].
    Ozaki M; Seno S; Shirakata M; Fujiyama N
    Nihon Rinsho; 1992 Jan; 50 Suppl():614-22. PubMed ID: 1315883
    [No Abstract]   [Full Text] [Related]  

  • 10. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
    Czyz W; Szepietowski T
    Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of growth hormone treatment on bone metabolism in dialysis patients.
    Sieniawska M; Pañczyk-Tomaszewska M; Ziólkowska H
    Br J Clin Pract Suppl; 1996 Aug; 85():61-3. PubMed ID: 8995036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of bone mineral content in patients with chronic renal failure.
    Gava A; Zorzetto M; Coghetto F; Teodori T; Marazzato G
    Rays; 1986; 11(3):67-70. PubMed ID: 3602467
    [No Abstract]   [Full Text] [Related]  

  • 13. [Disorders of amino acid metabolism in chronic renal insufficiency occurring during hemodialysis and methods of their treatment].
    Lopatkin NA; Chudnovskaia MV; Danilkov AP; Kuchinskii IN
    Urol Nefrol (Mosk); 1972; 37(5):24-9. PubMed ID: 4662064
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes of calcium-phosphorus metabolism in patients with chronic renal failure on hemodialysis treatment].
    Pérez Ruilópez MA; Damiano Rivero A; Herrerías Echabe JM; Garrido Peralta M
    Rev Iber Endocrinol; 1976; 23(138):535-55. PubMed ID: 1013577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controversial opinions regarding the role of Bcml vitamin D receptor gene polymorphism on parathyroid function, calcium absorption and bone mineral density in persons with normal renal function and patients with chronic renal failure].
    Maik J; Lochyńska K; Furmanowska A; Czekalski S
    Przegl Lek; 1999; 56(11):739-42. PubMed ID: 10800588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The causes of aluminum cumulation and poisoning in patients with chronic kidney failure treated by hemodialysis on a regular program and the possibilities for therapy].
    Válek A; Sulková S; Laurinová Z
    Ter Arkh; 1991; 63(6):89-93. PubMed ID: 1948757
    [No Abstract]   [Full Text] [Related]  

  • 17. Markers of bone metabolism in hemodialyses and hemodiafiltration.
    Małyszko J; Małyszko JS; Koźminski P; Pawlak K; Wołczynski S; Myśliwiec M
    Ren Fail; 2007; 29(5):595-601. PubMed ID: 17654323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium and phosphorus metabolism in maintenance hemodialysis.
    Ritz E; Mehls O; Krempien B
    Adv Nephrol Necker Hosp; 1980; 9():71-108. PubMed ID: 6773320
    [No Abstract]   [Full Text] [Related]  

  • 19. [Glucocorticoid metabolism in chronic kidney failure with hemodialysis maintenance therapy].
    Nomura H; Koni I; Takeda R
    Nihon Rinsho; 1992 Jan; 50 Suppl():580-3. PubMed ID: 1578741
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of bone mineral content in vivo in dialyzed patients using photon radiation absorptiometry].
    Sulková S; Stráník L; Zichová M; Zichová H; Lapcík O
    Cas Lek Cesk; 1990 Nov; 129(48):1520-3. PubMed ID: 2257601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.